FSCM
SRNE

Front Street Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Front Street Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,000
Closed -$21K – 72
2022
Q4 		$21K Hold
24,000
– – 0.01% 65
2022
Q3 		$38K Hold
24,000
– – 0.01% 67
2022
Q2 		$48K Hold
24,000
– – 0.01% 61
2022
Q1 		$56K Hold
24,000
– – 0.01% 61
2021
Q4 		$112K Buy
+24,000
New +$112K 0.02% 66